{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:24:33Z","timestamp":1792790673873,"version":"4.5.0"},"reference-count":152,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Silymarin is a polyphenolic flavonoid complex extricated from dried fruits and seeds of the plant <jats:italic>Silybum marianum<\/jats:italic> L. Chemically, it is a mixture of flavonolignan complexes consisting of silybin, isosilybin, silychristin, silydianin, a minor quantity of taxifolin, and other polyphenolic compounds, which possess different bio medicinal values.<\/jats:p><\/jats:sec><jats:sec><jats:title>Purpose<\/jats:title><jats:p>This review critically looks into the current status, pharmaceutical prospects and limitations of the clinical application of Silymarin for treating neurological disorders. In particular, Silymarin\u2019s medicinal properties and molecular mechanisms are focused on providing a better-compiled understanding helpful in its neuro-pharmacological or therapeutic aspects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This review was compiled by the literature search done using three databases, i.e., PubMed (Medline), EMBASE and Science Direct, up to January 2023, using the keywords-Silymarin, neurological disorders, cognitive disorders, Type 2 Diabetes, pharmaceutical prospects and treatment. Then, potentially relevant publications and studies (matching the eligible criteria) were retrieved and selected to explain in this review using PRISMA 2020 (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) study flow chart.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result<\/jats:title><jats:p>Since its discovery, it has been widely studied as a hepatoprotective drug for various liver disorders. However, in the last 10\u201315\u2009years, several research studies have shown its putative neuroprotective nature against various brain disorders, including psychiatric, neurodegenerative, cognitive, metabolic and other neurological disorders. The main underlying neuroprotective mechanisms in preventing and curing such disorders are the antioxidant, anti-inflammatory, anti-apoptotic, pro-neurotrophic and pro-estrogenic nature of the bioactive molecules.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This review provides a lucid summary of the well-studied neuroprotective effects of Silymarin, its underlying molecular mechanisms and current limitations for its usage during neurological disorders. Finally, we have suggested a future course of action for developing it as a novel herbal drug for the treatment of brain diseases.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2023.1159806","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T05:23:11Z","timestamp":1684387391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight"],"prefix":"10.3389","volume":"17","author":[{"given":"Shovit","family":"Ranjan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"107715","DOI":"10.1016\/j.intimp.2021.107715","article-title":"Significant immunomodulatory and hepatoprotective impacts of Silymarin in MS patients: a double-blind placebo-controlled clinical trial","volume":"97","author":"Abbasirad","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/brainsci10090628","article-title":"The possible neuroprotective effect of Silymarin against aluminum chloride-prompted Alzheimer's-like disease in rats","volume":"10","author":"Aboelwafa","year":"2020","journal-title":"Brain Sci."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.fitote.2016.05.012","article-title":"Silybum marianum pericarp yields enhanced silymarin products","volume":"112","author":"AbouZid","year":"2016","journal-title":"Fitoterapia"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fmolb.2015.00054","article-title":"Molecular diagnostics of neurodegenerative disorders","volume":"2","author":"Agrawal","year":"2015","journal-title":"Front. Mol. Biosci."},{"key":"ref9001","first-page":"1259","article-title":"Histological and immunohistochemical effects of L-arginine and silymarin on TNBS-induced inflammatory bowel disease in rats","volume":"31","author":"Al-Drees","year":"2016","journal-title":"Histol. Histopathol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/01480545.2018.1544984","article-title":"Glycyrrhizic acid and Silymarin alleviate the neurotoxic effects of aluminum in rats challenged with fructose-induced insulin resistance: possible role of toll-like receptor 4 pathway","volume":"42","author":"Ali","year":"2019","journal-title":"Drug Chem. Toxicol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/antiox8120608","article-title":"Natural compounds as beneficial antioxidant agents in neurodegenerative disorders: a focus on Alzheimer\u2019s disease","volume":"8","author":"Amato","year":"2019","journal-title":"Antioxidants"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.53350\/pjmhs22161820","article-title":"Evaluation of Antidiabetic effect of Silybum marianum and Cichorium intybus extracts","volume":"16","author":"Arshad","year":"2022","journal-title":"Pak. J. Med. Health Sci."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/ptr.3078","article-title":"Chronic treatment of Silymarin improves hyperalgesia and motor nerve conduction velocity in diabetic neuropathic rat","volume":"24","author":"Baluchnejadmojarad","year":"","journal-title":"Phytother. Res."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neulet.2010.06.038","article-title":"Neuroprotective effect of Silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress","volume":"480","author":"Baluchnejadmojarad","year":"","journal-title":"Neurosci. Lett."},{"key":"ref9002","first-page":"93","article-title":"Silymarin: a flavolignan with antidepressant activity","author":"Bansal","year":"2013","journal-title":"Int. J. Pharm. Innov."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1021\/acs.jnatprod.6b00750","article-title":"Silychristin: skeletal alterations and biological activities","volume":"79","author":"Biedermann","year":"2016","journal-title":"J. Nat. Prod."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/cns.12175","article-title":"Neuroprotective potential of Silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action","volume":"19","author":"Borah","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","article-title":"Depression and risk of developing dementia","volume":"7","author":"Byers","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.actbio.2012.02.011","article-title":"Oral bioavailability of Silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles","volume":"8","author":"Cao","year":"2012","journal-title":"Acta Biomater."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1745-4514.2011.00543.x","article-title":"Effect of Silymarin on lipid and alcohol metabolism in mice following long-term alcohol consumption","volume":"36","author":"Chou","year":"2012","journal-title":"J. Food Biochem."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"112004","DOI":"10.1016\/j.biopha.2021.112004","article-title":"Pharmacological basis and new insights of taxifolin: a comprehensive review","volume":"142","author":"Das","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/carcin\/bgm069","article-title":"Isosilybin B and isosilybin a inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells","volume":"28","author":"Deep","year":"2007","journal-title":"Carcinogenesis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3390\/molecules24112155","article-title":"Formulation strategies for enhancing the bioavailability of silymarin: the state of the art","volume":"24","author":"Di Costanzo","year":"2019","journal-title":"Molecules"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.neuron.2014.05.044","article-title":"The cost of brain diseases: a burden or a challenge?","volume":"82","author":"DiLuca","year":"2014","journal-title":"Neuron"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4103\/0253-7613.36534","article-title":"Silymarin: a review of pharmacological aspects and bioavailability enhancement approaches","volume":"39","author":"Dixit","year":"2007","journal-title":"Indian J. Pharmacol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2015.02.002","article-title":"Silibinin inhibits acetylcholinesterase activity and amyloid \u03b2 peptide aggregation: a dual-target drug for the treatment of Alzheimer\u2019s disease","volume":"36","author":"Duan","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1055\/a-0710-5673","article-title":"Silymarin prevents memory impairments, anxiety, and depressive-like symptoms in a rat model of post-traumatic stress disorder","volume":"85","author":"El-Elimat","year":"2019","journal-title":"Planta Med."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3889\/oamjms.2018.257","article-title":"Ameliorative effect of Silymarin on scopolamine-induced dementia in rats","volume":"6","author":"El-Marasy","year":"2018","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2165\/00044011-200222010-00007","article-title":"Pharmacology of Silymarin","volume":"22","author":"Fraschini","year":"2002","journal-title":"Clin. Drug Investig."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1016\/j.fct.2009.07.030","article-title":"Effect of Silymarin on biochemical parameters of oxidative stress in aged and young rat brain","volume":"47","author":"Galhardi","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1149\/2754-2726\/ac973e","article-title":"Towards modern-age advanced sensors for the management of neurodegenerative disorders: current status, challenges and prospects","volume":"1","author":"Gautam","year":"2022","journal-title":"ECS Sensors Plus."},{"key":"ref26","volume-title":"Psychological Science","author":"Gazzaniga","year":"2006"},{"key":"ref27","first-page":"387","article-title":"Anaphylactic shock due to an extract of Silybum marianum in a patient with immediate-type allergy to kiwi fruit","volume":"13","author":"Geier","year":"1990","journal-title":"Allergologie"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bcpt.12088","article-title":"Immunosuppressive effect of silymarin on mitogen-activated protein kinase signalling pathway: the impact on T cell proliferation and cytokine production","volume":"113","author":"Gharagozloo","year":"","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/bcpt.12032","article-title":"Silymarin inhibits cell cycle progression and m TOR activity in activated human T cells: therapeutic implications for autoimmune diseases","volume":"112","author":"Gharagozloo","year":"","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref9003","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.intimp.2013.04.016","article-title":"Immunomodulatory effects of silymarin in patients with \u03b2-thalassemia major","volume":"16","author":"Gharagozloo","year":"","journal-title":"Int. Immunopharmacol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.phrs.2009.12.017","article-title":"Silymarin suppress CD4+ T cell activation and proliferation: effects on NF-\u03baB activity and IL-2 production","volume":"61","author":"Gharagozloo","year":"2010","journal-title":"Pharmacol. Res."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e22800","DOI":"10.1002\/jbt.22800","article-title":"Antioxidative effects of Silymarin on the reduction of liver complications of fingolimod in patients with relapsing\u2013remitting multiple sclerosis: a clinical trial study","volume":"35","author":"Ghiasian","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref32","first-page":"348","article-title":"Silymarin-a review on the pharmacodynamics and bioavailability enhancement approaches","volume":"2","author":"Ghosh","year":"2010","journal-title":"J. Pharm. Sci. Technol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/JCP.0000000000000327","article-title":"Silymarin treatment of obsessive-compulsive spectrum disorders","volume":"35","author":"Grant","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1080\/13880209.2016.1199042","article-title":"Silymarin improved diet-induced liver damage and insulin resistance by decreasing inflammation in mice","volume":"54","author":"Guo","year":"2016","journal-title":"Pharm. Biol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jep.2016.07.060","article-title":"Combination of Zizyphus jujuba and Silymarin showed better neuroprotective effect as compared to single agent in MCAo-induced focal cerebral ischemia in rats","volume":"197","author":"Gupta","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s11011-021-00704-9","article-title":"Protective mechanism of Syringic acid in an experimental model of Parkinson\u2019s disease","volume":"36","author":"Guzelad","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"463","DOI":"10.15171\/apb.2015.063","article-title":"Short-term treatment with Silymarin improved 6-OHDA-induced catalepsy and motor imbalance in hemi-parkisonian rats","volume":"5","author":"Haddadi","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1007\/s00210-020-01954-7","article-title":"Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment","volume":"393","author":"Haddadi","year":"","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neulet.2013.09.022","article-title":"Pre-treatment with Silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats","volume":"555","author":"Haddadi","year":"2013","journal-title":"Neurosci. Lett."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.biopha.2018.05.020","article-title":"Silymarin prevents apoptosis through inhibiting the Bax\/caspase-3 expression and suppresses toll like receptor-4 pathway in the SNc of 6-OHDA intoxicated rats","volume":"104","author":"Haddadi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"153320","DOI":"10.1016\/j.phymed.2020.153320","article-title":"Silymarin and neurodegenerative diseases: therapeutic potential and basic molecular mechanisms","volume":"79","author":"Haddadi","year":"","journal-title":"Phytomedicine"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.beth.2014.03.001","article-title":"Toward a cognitive-behavioral classification system for mental disorders","volume":"45","author":"Hofmann","year":"2014","journal-title":"Behav. Ther."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.phymed.2010.03.012","article-title":"Preventive effect of Silymarin in cerebral ischemia\u2013reperfusion-induced brain injury in rats possibly through impairing NF-\u03baB and STAT-1 activation","volume":"17","author":"Hou","year":"2010","journal-title":"Phytomedicine"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.3892\/etm.2017.4410","article-title":"Multiple sclerosis: pathology, diagnosis and treatments","volume":"13","author":"Huang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/ptr.1988","article-title":"The efficacy of Silybum marianum (L.) Gaertn.(Silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial","volume":"20","author":"Huseini","year":"2006","journal-title":"Phytother. Res."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3109\/02652048.2014.911375","article-title":"A novel solid dispersion system for natural product-loaded medicine: silymarin-loaded solid dispersion with enhanced oral bioavailability and hepatoprotective activity","volume":"31","author":"Hwang","year":"2014","journal-title":"J. Microencapsul."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.parkreldis.2010.06.014","article-title":"Occurrence of depression and anxiety prior to Parkinson\u2019s disease","volume":"16","author":"Jacob","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S0002-9343(02)01244-5","article-title":"Milk thistle for the treatment of liver disease: a systematic review and meta-analysis","volume":"113","author":"Jacobs","year":"2002","journal-title":"Am. J. Med."},{"key":"ref50","first-page":"239","article-title":"Reassessing bioavailability of Silymarin","volume":"16","author":"Javed","year":"2011","journal-title":"Altern. Med. Rev."},{"key":"ref51","first-page":"131","article-title":"Comparison of the effects of thymoquinone and Silymarin on the brain of rats having ischemia-reperfusion in the lower extremities","volume":"91","author":"Karabag","year":"2020","journal-title":"Ann. Ital. Chir."},{"key":"ref52","first-page":"308","article-title":"\"Silymarin\", a promising pharmacological agent for the treatment of diseases","volume":"14","author":"Karimi","year":"2011","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.taap.2006.11.011","article-title":"Silymarin and epithelial cancer chemoprevention: how close we are to bedside?","volume":"224","author":"Kaur","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"102021","DOI":"10.1016\/j.jddst.2020.102021","article-title":"An overview of advanced formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of silymarin","volume":"60","author":"Kesharwani","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref55","first-page":"545","article-title":"Study of the physicochemical properties of Silybum marianum Saeed oil","volume":"29","author":"Khan","year":"2007","journal-title":"J. Chem. Soc. Pak."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2174\/187152708783885183","article-title":"Stem cells for the treatment of neurological disorders","volume":"7","author":"Khanna","year":"2008","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3109\/13880209.2014.942787","article-title":"Possible involvement of nitric oxide in antidepressant-like effect of Silymarin in male mice","volume":"53","author":"Khoshnoodi","year":"2015","journal-title":"Pharm. Biol."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.taap.2017.11.012","article-title":"Anxiolytic-and antidepressant-like effects of Silymarin compared to diazepam and fluoxetine in a mouse model of mild traumatic brain injury","volume":"338","author":"Kosari-Nasab","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"6237160","DOI":"10.1155\/2020\/6237160","article-title":"Phytochemicals from selective plants have promising potential against SARS-CoV-2: investigation and corroboration through molecular docking, MD simulations, and quantum computations","volume":"2020","author":"Kousar","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5507\/bp.2005.002","article-title":"Silybin and silymarin-new effects and applications","volume":"149","author":"K\u0159en","year":"2005","journal-title":"Biomed Papers"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2174\/1871527314666150116110212","article-title":"Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer\u2019s model","volume":"14","author":"Kumar","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref9004","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.pharep.2014.04.007","article-title":"Silymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cells","volume":"66","author":"Kumar","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.17221\/7846-VETMED","article-title":"Estrogenic effects of Silymarin in ovariectomized rats","volume":"46","author":"Kummer","year":"2001","journal-title":"Vet. Med."},{"key":"ref63","first-page":"3775","article-title":"Radioprotective potentials of Silymarin\/Silibinin against radiotherapy-induced toxicities: a systematic review of clinical and experimental studies","volume-title":"Curr. Med. Chem.","author":"Latacela","year":"2023"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ijbiomac.2021.09.173","article-title":"Syringic acid demonstrates promising protective effect against tau fibrillization and cytotoxicity through regulation of endoplasmic reticulum stress-mediated pathway as a prelude to Alzheimer's disease","volume":"192","author":"Li","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1124\/jpet.109.155069","article-title":"Silibinin attenuates amyloid \u03b225\u201335 peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-\u03b1 in mice","volume":"331","author":"Lu","year":"","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.bbr.2009.10.024","article-title":"Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment","volume":"207","author":"Lu","year":"2010","journal-title":"Behav. Brain Res."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/j.1476-5381.2009.00295.x","article-title":"Silibinin prevents amyloid \u03b2 peptide-induced memory impairment and oxidative stress in mice","volume":"157","author":"Lu","year":"","journal-title":"Br. J. Pharmacol."},{"key":"ref68","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6661191","article-title":"Virtual screening of phytochemicals by targeting HR1 domain of SARS-CoV-2 S protein: molecular docking, molecular dynamics simulations, and DFT studies.","volume-title":"Biomed Res. Int.","author":"Majeed","year":"2021"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jpain.2011.11.009","article-title":"Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin","volume":"13","author":"Mannelli","year":"2012","journal-title":"J. Pain"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2013.03.019","article-title":"Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy?","volume":"61","author":"Mannelli","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.pnpbp.2011.03.017","article-title":"Involvement of serotonergic system in the antidepressant-like effect of piperine","volume":"35","author":"Mao","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref72","first-page":"54","volume-title":"Global Burden of Disease in 2002: Data Sources, Methods and Results","author":"Mathers","year":"2003"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1365-2893.2005.00636.x","article-title":"Silymarin treatment of viral hepatitis: a systematic review","volume":"12","author":"Mayer","year":"2005","journal-title":"J. Viral Hepatitis"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1124\/dmd.108.021790","article-title":"Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2)","volume":"36","author":"Miranda","year":"2008","journal-title":"Drug Metab. Disposition"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"173066","DOI":"10.1016\/j.ejphar.2020.173066","article-title":"Preventive effect of silymarin-loaded chitosan nanoparticles against global cerebral ischemia\/reperfusion injury in rats","volume":"877","author":"Moghaddam","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF03188811","article-title":"Comparative pharmacokinetics of silipide and Silymarin in rats","volume":"18","author":"Morazzoni","year":"1993","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref9005","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1053\/j.gastro.2009.09.021","article-title":"Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection","volume":"138","author":"Morishima","year":"2010","journal-title":"Gastroenterology"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.lfs.2013.05.020","article-title":"Amelioration of cognitive, motor and endogenous defense functions with Silymarin, piracetam and protocatechuic acid in the cerebral global ischemic rat model","volume":"93","author":"Muley","year":"2013","journal-title":"Life Sci."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.pbb.2012.05.004","article-title":"Silymarin improves the behavioural, biochemical and histoarchitecture alterations in focal ischemic rats: a comparative evaluation with piracetam and protocatachuic acid","volume":"102","author":"Muley","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"P510","DOI":"10.1016\/j.jalz.2013.05.1068","article-title":"P2\u2013418: vitamin C and Silymarin restores beta-amyloid oligomerization and behavioral abnormality in Alzheimer's disease pathology","volume":"9","author":"Murakami","year":"2013","journal-title":"Alzheimers Dement."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1271\/bbb.100524","article-title":"Silymarin attenuated the amyloid \u03b2 plaque burden and improved behavioral abnormalities in an Alzheimer\u2019s disease mouse model. Biosci., Biotechnol","volume":"74","author":"Murata","year":"2010","journal-title":"Biochemist"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s10753-018-0872-x","article-title":"Immunoregulatory effects of Silymarin on proliferation and activation of Th1 cells isolated from newly diagnosed and IFN-ss1b-treated MS patients","volume":"42","author":"Navabi","year":"2019","journal-title":"Inflammation"},{"key":"ref9006","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/ptr.3175","article-title":"Effect of silymarin administration on TNF-\u03b1 serum concentration in peritoneal dialysis patients","volume":"24","author":"Nazemian","year":"2010","journal-title":"Phytother. Res."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00210-014-0990-4","article-title":"Silymarin ameliorates memory deficits and neuropathological changes in mouse model of high-fat-diet-induced experimental dementia","volume":"387","author":"Neha","year":"2014","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.phymed.2006.02.005","article-title":"Protective effect of Silymarin on oxidative stress in rat brain","volume":"14","author":"Nencini","year":"2007","journal-title":"Phytomedicine"},{"key":"ref9007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-319-41342-6_2","article-title":"Silymarin and its role in chronic diseases","volume-title":"Drug Discovery from Mother Nature","author":"Neha","year":"2016"},{"key":"ref84","first-page":"4","article-title":"Relationship of neurotransmitters to the symptoms of major depressive disorder","volume":"69","author":"Nutt","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1080\/00207454.2020.1849191","article-title":"The influence of syringic acid treatment on total dopamine levels of the hippocampus and on cognitive behavioral skills","volume":"132","author":"Ogut","year":"","journal-title":"Int. J. Neurosci."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s11011-022-00960-3","article-title":"The role of syringic acid as a neuroprotective agent for neurodegenerative disorders and future expectations","volume":"37","author":"Ogut","year":"","journal-title":"Metab. Brain Dis."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"106839","DOI":"10.1016\/j.ntt.2019.106839","article-title":"Protective effects of syringic acid on neurobehavioral deficits and hippocampal tissue damages induced by sub-chronic deltamethrin exposure","volume":"76","author":"Ogut","year":"2019","journal-title":"Neurotoxicol. Teratol."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/13880200490519712","article-title":"Alterations in regional brain neurotransmitters by Silymarin, a natural antioxidant flavonoid mixture, in BALB\/c mice","volume":"42","author":"Osuchowski","year":"2004","journal-title":"Pharm. Biol."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jconrel.2021.05.046","article-title":"Tailoring of P-glycoprotein for effective transportation of actives across blood-brain-barrier","volume":"335","author":"Pathan","year":"2021","journal-title":"J. Control. Release"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/ajhp\/56.12.1195","article-title":"Milk thistle: Silybum marianum","volume":"56","author":"Pepping","year":"1999","journal-title":"Am. J. Health System Pharm."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3390\/antiox10111845","article-title":"The emerging scenario of the gut\u2013brain axis: the therapeutic actions of the new actor kefir against neurodegenerative diseases","volume":"10","author":"Pereira","year":"2021","journal-title":"Antioxidants"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/ijms17081273","article-title":"Coadjuvants in the diabetic complications: nutraceuticals and drugs with pleiotropic effects","volume":"17","author":"Pereira","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.tox.2014.02.009","article-title":"Neuroprotective effect of Silymarin in a MPTP mouse model of Parkinson's disease","volume":"319","author":"P\u00e9rez-H","year":"2014","journal-title":"Toxicology"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/pdi.1945","article-title":"Silymarin","volume":"32","author":"Petrie","year":"2015","journal-title":"Pract. Diabetes"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.tox.2005.06.020","article-title":"Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation","volume":"215","author":"Pl\u00ed\u0161kov\u00e1","year":"2005","journal-title":"Toxicology"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.fitote.2017.04.008","article-title":"New amides from seeds of Silybum marianum with potential antioxidant and antidiabetic activities","volume":"119","author":"Qin","year":"2017","journal-title":"Fitoterapia"},{"key":"ref97","first-page":"1285","article-title":"Milk thistle","volume":"72","author":"Rainone","year":"2005","journal-title":"Am. Fam. Physician"},{"key":"ref9008","doi-asserted-by":"publisher","first-page":"246","DOI":"10.5958\/2320-3188.2020.00028.5","article-title":"Gender Specific Effect of Brain-Derived Neurotrophic Factor (BDNF) Gene SNP G196A on Susceptibility to Alzheimer\u2019s Disease: A Meta-Analysis","author":"Ranjan","year":"2020","journal-title":"Bulletin of Pure & Applied Sciences- Zoology"},{"key":"ref9009","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.26717\/BJSTR.2018.06.001314","article-title":"Association of Brain-derived Neurotrophic Factor (BDNF) Gene SNPs G196A and C270T with Parkinson\u2019s disease: A Meta- Analysis","volume":"2018","author":"Ranjan","year":"2018","journal-title":"Biomed. J. Sci. Tech. Res."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1186\/s40064-016-3267-1","article-title":"Natural flavonoids Silymarin and quercetin improve the brain distribution of co-administered P-gp substrate drugs","volume":"5","author":"Ravikumar Reddy","year":"2016","journal-title":"Springerplus"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jns.2011.07.035","article-title":"Silymarin protects neurons from oxidative stress associated damages in focal cerebral ischemia: a behavioral, biochemical and immunohistological study in Wistar rats","volume":"309","author":"Raza","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1055\/s-1999-14085","article-title":"Prevention by a silymarin\/phospholipid compound of ethanol-induced social learning deficits in rats","volume":"65","author":"Reid","year":"1999","journal-title":"Planta Med."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.trsl.2011.12.003","article-title":"Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis","volume":"159","author":"Salamone","year":"2012","journal-title":"Transl. Res."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.2165\/00003495-200161140-00003","article-title":"The use of Silymarin in the treatment of liver diseases","volume":"61","author":"Saller","year":"2001","journal-title":"Drugs"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/liv.12975","article-title":"Natural antioxidants for nonalcoholic fatty liver disease: molecular targets and clinical perspectives","volume":"36","author":"Salomone","year":"2016","journal-title":"Liver Int."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1515\/pjfns-2015-0014","article-title":"Effects of Silybum marianum extract on high-fat diet induced metabolic disorders in rats","volume":"66","author":"Sayin","year":"2016","journal-title":"Polish J. Food Nutr. Sci."},{"key":"ref105","first-page":"410","article-title":"A review of plants used in the treatment of liver disease: part 1","volume":"3","author":"Scott Luper","year":"1998","journal-title":"Altern. Med. Rev."},{"key":"ref106","first-page":"45","article-title":"The effect of Silymarin on prevention of hippocampus neuronal damage in rats with temporal lob epilepsy","volume":"5","author":"Sedaghat","year":"2017","journal-title":"J. Basic Clin. Pathophysiol."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0960-0760(03)00270-X","article-title":"Silymarin is a selective estrogen receptor \u03b2 (ER\u03b2) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats","volume":"86","author":"Seidlova-Wuttke","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s10753-019-00980-9","article-title":"Silymarin restores regulatory t cells (TREGS) function in multiple sclerosis (MS) patients in vitro","volume":"42","author":"Shariati","year":"2019","journal-title":"Inflammation"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"7141","DOI":"10.1007\/s00253-019-09950-5","article-title":"Regulation of gut microbiota in Alzheimer's disease mice by silibinin and Silymarin and their pharmacological implications","volume":"103","author":"Shen","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.ijbiomac.2020.02.041","article-title":"Silymarin encapsulated nanoliquid crystals for improved activity against beta amyloid induced cytotoxicity","volume":"149","author":"Singh","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1600-079X.2010.00819.x","article-title":"Melatonin or Silymarin reduces maneb-and paraquat-induced Parkinson's disease phenotype in the mouse","volume":"50","author":"Singhal","year":"2011","journal-title":"J. Pineal Res."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/ptr.6361","article-title":"Safety and toxicity of Silymarin, the major constituent of milk thistle extract: an updated review","volume":"33","author":"Soleimani","year":"2019","journal-title":"Phytother. Res."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.physbeh.2017.07.023","article-title":"Silibinin ameliorates anxiety\/depression-like behaviors in amyloid \u03b2-treated rats by upregulating BDNF\/TrkB pathway and attenuating autophagy in hippocampus","volume":"179","author":"Song","year":"2017","journal-title":"Physiol. Behav."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1507834","DOI":"10.1155\/2018\/1507834","article-title":"The bioavailability and pharmacokinetics of silymarin SMEDDS formulation study in healthy thai volunteers","volume":"2018","author":"Sornsuvit","year":"2018","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"112066","DOI":"10.1016\/j.phytochem.2019.112066","article-title":"An insight into the health-promoting effects of taxifolin (dihydroquercetin)","volume":"166","author":"Sunil","year":"2019","journal-title":"Phytochemistry"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10787-022-00961-9","article-title":"Silymarin constrains diacetyl-prompted oxidative stress and neuroinflammation in rats: involvements of Dyn\/GDNF and MAPK signaling pathway","volume":"30","author":"Tabaa","year":"2022","journal-title":"Inflammopharmacology"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/ptr.6153","article-title":"Silybum marianum (milk thistle) and its main constituent, Silymarin, as a potential therapeutic plant in metabolic syndrome: a review","volume":"32","author":"Tajmohammadi","year":"2018","journal-title":"Phytother. Res."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.physbeh.2017.07.010","article-title":"Silymarin ameliorates experimentally induced depressive-like behavior in rats: involvement of hippocampal BDNF signaling, inflammatory cytokines and oxidative stress response","volume":"179","author":"Thakare","year":"2017","journal-title":"Physiol. Behav."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.pharep.2016.06.002","article-title":"Potential antidepressant-like activity of Silymarin in the acute restraint stress in mice: modulation of corticosterone and oxidative stress response in cerebral cortex and hippocampus","volume":"68","author":"Thakare","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0269881117742666","article-title":"Therapeutic potential of Silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice","volume":"32","author":"Thakare","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jss.2007.03.072","article-title":"Silymarin, the antioxidant component of Silybum marianum, prevents sepsis-induced acute lung and brain injury","volume":"145","author":"Toklu","year":"2008","journal-title":"J. Surg. Res."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00213-001-0926-9","article-title":"Difference in serotonergic and noradrenergic regulation of human social behaviours","volume":"159","author":"Tse","year":"2002","journal-title":"Psychopharmacology"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fphar.2018.00422","article-title":"Anti-Parkinson potential of Silymarin: mechanistic insight and therapeutic standing","volume":"9","author":"Ullah","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref9010","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10517-007-0252-2","article-title":"Effects of silymarin (hepatoprotector) and succinic acid (bioenergy regulator) on metabolic disorders in experimental diabetes mellitus","volume":"144","author":"Vengerovskii","year":"2007","journal-title":"Bulletin of Experimental Biology and Medicine"},{"key":"ref125","first-page":"466","article-title":"The chemistry and analysis of silymarin from Silybum marianum Gaertn","volume":"24","author":"Wagner","year":"1974","journal-title":"Arzneimittelforschung"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1046\/j.1460-9568.2002.02290.x","article-title":"Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation","volume":"16","author":"Wang","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neulet.2012.08.078","article-title":"Protection by silibinin against experimental ischemic stroke: upregulated pAkt, pmTOR, HIF-1\u03b1 and Bcl-2, down-regulated Bax, NF-\u03baB expression","volume":"529","author":"Wang","year":"2012","journal-title":"Neurosci. Lett."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"e0143625","DOI":"10.1371\/journal.pone.0143625","article-title":"A new type of liquid silymarin proliposome containing bile salts: its preparation and improved hepatoprotective effects","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/BF02977782","article-title":"Formulation and biopharmaceutical evaluation of Silymarin using SMEDDS","volume":"30","author":"Woo","year":"2007","journal-title":"Arch. Pharm. Res."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00415-017-8632-7","article-title":"The economic burden of chronic neurological disease","volume":"264","author":"Wynford-Thomas","year":"2017","journal-title":"J. Neurol."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nature20411","article-title":"Ageing, neurodegeneration and brain rejuvenation","volume":"539","author":"Wyss-Coray","year":"2016","journal-title":"Nature"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.3390\/molecules24203693","article-title":"Metabolism, transport and drug\u2013drug interactions of Silymarin","volume":"24","author":"Xie","year":"2019","journal-title":"Molecules"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2008-2231-22-24","article-title":"Silymarin effect on amyloid-\u03b2 plaque accumulation and gene expression of APP in an Alzheimer\u2019s disease rat model","volume":"22","author":"Yaghmaei","year":"2014","journal-title":"DARU J. Pharm. Sci."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4062\/biomolther.2014.138","article-title":"Protective effects of silibinin and its possible mechanism of action in mice exposed to chronic unpredictable mild stress","volume":"23","author":"Yan","year":"2015","journal-title":"Biomol. Ther."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.2147\/IJN.S50683","article-title":"Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation","volume":"8","author":"Yang","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"6633","DOI":"10.2147\/IJN.S92665","article-title":"Enhanced oral bioavailability of Silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo","volume":"10","author":"Yang","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1590\/1414-431X20122551","article-title":"Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with nonalcoholic fatty liver","volume":"46","author":"Yao","year":"2013","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.neuint.2010.12.017","article-title":"Silibinin: a novel inhibitor of A\u03b2 aggregation","volume":"58","author":"Yin","year":"2011","journal-title":"Neurochem. Int."},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2018-0109","article-title":"The effect of silymarin supplementation on cognitive impairment induced by diabetes in rats","volume":"30","author":"Y\u00f6n","year":"2019","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.biopha.2017.06.018","article-title":"Silymarin prevents NLRP3 inflammasome activation and protects against intracerebral hemorrhage","volume":"93","author":"Yuan","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref141","first-page":"153","article-title":"Role of tangeretin as a potential bioavailability enhancer for Silybin: pharmacokinetic and pharmacological studies","volume-title":"Pharmacol. Res.","author":"Yuan","year":"2018"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.biopha.2017.02.016","article-title":"Safety and efficacy of a polyherbal formulation for the management of dyslipidemia and hyperglycemia in patients with advanced-stage of type-2 diabetes","volume":"89","author":"Zarvandi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.fitote.2014.05.016","article-title":"Silymarin and its constituents in cardiac preconditioning","volume":"97","author":"Zholobenko","year":"2014","journal-title":"Fitoterapia"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"e9061","DOI":"10.1097\/MD.0000000000009061","article-title":"The therapeutic effect of Silymarin in the treatment of nonalcoholic fatty disease: a meta-analysis (PRISMA) of randomized control trials","volume":"96","author":"Zhong","year":"2017","journal-title":"Medicine"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1159806\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T05:23:31Z","timestamp":1684387411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1159806\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":152,"alternative-id":["10.3389\/fnins.2023.1159806"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1159806","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"article-number":"1159806"}}